• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The severity of neurocognitive impairment

Bioengineer by Bioengineer
April 12, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time. Moreover, cognitive dysfunction in this population may have a significant negative impact on quality of life, activities of daily living, independence and employment status.

Although several neuropsychological studies have compared the cognitive functions of patients between the three conventional clinical types (Relapsing Remitting – RRMS, Secondary – Progressive – SPMS and Primary Progressive – PPMS), results have been contradictory regarding neurocognitive deficit severity and pattern. The article by Ntoskou et al., provides further evidence that MS patients irrespective of clinical subtype, disease duration and severity, present with cognitive deficits compared to demographically and intellectually matched healthy individuals. Moreover, the study found that when MS patients convert from RRMS to SPMS, their cognitive abilities decline. Although they do not differ on overall global cognitive function, they differ on important cognitive abilities such as learning new information, speed of mental processing, ability to inhibit overlearned responses and mental flexibility. These cognitive deficits have a significant impact on everyday functioning abilities and quality of life. Contrary to the findings noted by the study regarding neurocognitive differences in terms of severity (quantitative) between the RRMS and SPMS patients, the pattern of impairment (qualitative) remains relatively stable, i.e. both patient types have impaired new learning and episodic memory, mental processing speed and executive dysfunction.

###

The article is available here: https://benthamopen.com/ABSTRACT/TONEUJ-12-19

Reference: Messinis L, et al. Cognitive and Language Deficits in Multiple Sclerosis: Comparison of Relapsing Remitting and Secondary Progressive Subtypes. The Open Neurology Journal, 2017, Vol 12, DOI: 10.2174/1874205X01812010019

Media Contact

Faizan ul Haq
[email protected]
@BenthamScienceP

http://benthamscience.com/

http://dx.doi.org/10.2174/1874205X01812010019

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Brain Area 46: The Hub of Emotion Regulation in Marmosets

August 22, 2025
BeginNGSĀ® Newborn Genome Sequencing Program Expands Global Reach Through Collaboration with Sidra Medicine in Qatar

BeginNGSĀ® Newborn Genome Sequencing Program Expands Global Reach Through Collaboration with Sidra Medicine in Qatar

August 22, 2025

A Decade of Migrasome Research: Biogenesis, Functions, Diseases

August 22, 2025

Microhaplotype Panel Advances Brazilian Human Identification

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Brain Area 46: The Hub of Emotion Regulation in Marmosets

New Insights into the Cumulative HBsAg/HBV DNA Ratio in Immune-Tolerant Hepatitis B Patients

Anti-PD-1 Boosts Gastric Cancer with Hepatitis B

  • Contact Us

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org Ā© Copyright 2023 All Rights Reserved.